Reliance Industries, the heavyweight of Dalal Street, is set to announce its Q3 earnings today, and the numbers could decide market direction for the coming week. Expectations are high as investors ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results